Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 24, 2022
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
[ Mon, Oct 24th 2022
] - WOPRAI
Justin Bowers Maintained (AMED) at Strong Buy with Decreased Target to $165 on, Oct 24th, 2022
Justin Bowers of Deutsche Bank, Maintained "Amedisys, Inc." (AMED) at Strong Buy with Decreased Target from $175 to $165 on, Oct 24th, 2022.
Justin has made no other calls on AMED in the last 4 months.
There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 1 agrees with Justin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
These are the ratings of the 5 analyists that currently disagree with Justin
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $140 on, Wednesday, October 5th, 2022
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
- Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
- John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $140 on, Monday, August 1st, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
